Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Sunitinib Malate Capsules

Approval Number

国药准字HJ20171143

CompanyPfizer Europe MA EEIG

Registration Date

July 29, 2022

Previous Approval Numbers

H20171143

Drug Information

Generic Name

苹果酸舒尼替尼胶囊

Trade Name

索坦

Dosage Form

胶囊剂

Strength

50mg

Drug Type

化学药品

Registration Date

July 29, 2022

Expiry Date

July 28, 2027

Company Information

Applicant Company

Company NamePfizer Europe MA EEIG

Company Address

Boulevard de la Plaine 17, 1050 Bruxelles, Belgium

Manufacturing Company

Company NamePfizer Italia S.R.L.

Company Address

Località Marino del Tronto, 63100 Ascoli Piceno, Italy

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy